Phone us+65 6887 6038

DNV has expertise in the area of biorisk (addressing biosafety and biosecurity), and has worked with a number of internationally recognised institutes and companies ranging from in conducting audits, design reviews and risk assessments of their biocontainment facilities.
Our biorisk team has not only have experience in assessing the physical requirements of the biorisks of biological containment, but also has expertise in assessing the laboratory biorisk management system within an organisation. At DNV, we place equal emphasis upon other organisation issues and ensuring the stakeholders are provided with an assurance that the organisation has taken and implemented reasonable measures and controls to reduce risks associated with biological agents.
Using a risk-based approach, our biorisk team can help your facility and organisation to identify risks and hazards derived from biological agents and their products. We believe this approach is a proactive and preventative risk management measures that not only ensure regulatory compliance, but also greatly reduce the risk of harm to people and the environment, whist improving business performance.
With the growing awareness of risk associated with biological agents and toxins, formal certification will provide an assurance that the biorisk management system is effectively implemented and regulatory requirements are fulfilled. It is also a public declaration of organisation’s commitment to protect the staff, the community and the wider environment.
A process whereby a laboratory is independently assessed and certified against criteria derived from the World Health Organisation Biosafety Manual. The approach reflects internationally recognised certification principles.

Indonesia is now the country with the highest number of human fatalities caused by the H5N1 influenza virus, often referred to as ‘avian flu’. In an effort to tackle the deadly disease, the prestigious Eijkman Institute in Jakarta has built a new biosafety level 3 (BSL3) laboratory – with the help of DNV.

The Agency for Science, Technology and Research (A*STAR) is leading the way in biomedical research – with the help of DNV.